Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03101839
Title Phase I Dose-Escalation Study of AZD4785 in Patients With Advanced Solid Tumours
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications

Advanced Solid Tumor

lung non-small cell carcinoma

Therapies

AZD4785

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.